Plasma cell-free circulating tumor DNA (ctDNA) detection in longitudinally followed glioblastoma patients using <i>TERT</i> promoter mutation-specific droplet digital PCR assays.Christine Cordova, Sylvia C. Kurz, Malcolm Delara et al.|Journal of Clinical Oncology|2019Cited by 12
ATIM-37. PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RADIATION (HFRT) FOR ADULT PATIENTS WITH SECONDARILY TRANSFORMED IDH-MUTANT GLIOBLASTOMA (GBM)Sylvia C. Kurz, Joshua S. Silverman, Tsivia Hochman et al.|Neuro-Oncology|2019Cited by 3
Abstract A65: Longitudinal detection of TERT-mutant plasma cell-free circulating tumor DNA in newly diagnosed glioblastoma patientsChristine Cordova, Mahrukh M. Syeda, Broderick C. Corless et al.|Clinical Cancer Research|2020Cited by 1
ATIM-01. A PHASE II, OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY OF AVELUMAB WITH HYPOFRACTIONATED RE-IRRADIATION IN ADULT SUBJECTS WITH TRANSFORMED IDH MUTANT GLIOBLASTOMAJoshua S. Silverman, Sylvia Eisele, Isabel Arrillaga‐Romany et al.|Neuro-Oncology|2017Cited by 0
PATH-42. DETECTION OF TERT MUTATIONS IN CELL-FREE CIRCULATING TUMOR DNA (ctDNA) OF GLIOBLASTOMA PATIENTS USING DROPLET DIGITAL PCRChristine Cordova, Broderick C. Corless, Mahrukh M. Syeda et al.|Neuro-Oncology|2017Cited by 0